Adjusting for centre heterogeneity in multicentre clinical trials with a time-to-event outcome

Pharmaceutical Statistics

Volumn 13, Issue 2, 2014, Pages 145-152

  Munda, Marco ^a   Legrand, Catherine ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

frailty distribution misspecification; frailty model; multicentre clinical trial; time to event outcome

Indexed keywords

ARTICLE; HUMAN; MODEL; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRACTICE GUIDELINE; SIMULATION; THE FIXED EFFECT APPROACH; THE STRATIFIED APPROACH; THE UNADJUSTED APPROACH; COMPUTER SIMULATION; PROPORTIONAL HAZARDS MODEL; STATISTICAL ANALYSIS; STATISTICAL MODEL;

COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; MULTICENTER STUDIES AS TOPIC; PROPORTIONAL HAZARDS MODELS;

EID: 84896701450     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1612     Document Type: Article

References (17)

1. Glidden DV, Vittinghoff E,. Modelling clustered survival data from multicentre clinical trials. Statistics in Medicine 2004; 23: 369-388.
2. Gill RD,. Understanding Cox's regression model: a martingale approach. Journal of the American Statistical Association 1984; 79: 441-447.
3. Duchateau L, Janssen P,. The frailty model. Springer: New York, 2008.
4. Wienke A,. Frailty models in survival analysis. Chapman and Hall/CRC: Boca Raton, 2010.
5. Cortiñas Abrahantes J, Legrand C, Burzykowski T, Janssen P, Ducrocq V, Duchateau L,. Comparison of different estimation procedures for proportional hazards model with random effects. Computational Statistics & Data Analysis 2007; 51: 3913-3930.
6. Munda M, Rotolo F, Legrand C,. parfm: parametric frailty models in R. Journal of Statistical Software 2012; 51: 1-20.
7. Hirsch K, Wienke A,. Software for semiparametric shared gamma and log-normal frailty models: an overview. Computer Methods and Programs in Biomedicine 2012; 107: 582-597.
8. Therneau TM, Grambsch PM,. Modeling survival data: extending the cox model. Springer: New York, 2000.
9. Clahsen PC, van de Velde CJ, Julien JP, Floiras JL, Delozier T, Mignolet FY, Sahmoud TM,. Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. Journal of Clinical Oncology 1996; 14: 745-753.
10. van der Hage JA, van de Velde CJ, Julien JP, Floiras JL, Delozier T, Vandervelden C, Duchateau L,. Improved survival after one course of perioperative chemotherapy in early breast cancer patients: long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854. European Journal of Cancer 2001; 37: 2184-2193.
11. Duchateau L, Janssen P,. Understanding heterogeneity in generalized mixed and frailty models. The American Statistician 2005; 59: 143-146.
12. Collett D,. Modelling survival data in medical research. Chapman and Hall/CRC: London, 2003.
13. Burton A, Altman DG, Royston P, Holder RL,. The design of simulation studies in medical statistics. Statistics in Medicine 2006; 25: 4279-4292.
14. Hauck WW, Anderson S, Marcus SM,. Should we adjust for covariates in nonlinear regression analyses of randomized trials? Controlled Clinical Trials 1998; 19: 249-256.
15. Andersen PK, Klein JP, Zhang MJ,. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Statistics in Medicine 1999; 18: 1489-1500.
16. Legrand C, Duchateau L, Sylvester R, Janssen P, van der Hage JA, van de Velde CJ, Therasse P,. Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trial. Clinical Trials 2006; 3: 10-18.
17. Hougaard P,. Analysis of multivariate survival data. Springer: New York, 2000.